Proglycem Suspension 017453 1
Proglycem Suspension
Product Images NDC 0575-6200
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Proglycem (NDC 0575-6200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Proglycem Suspension 017453 2
This appears to be a description of a medication called Proglycem, which comes in an oral suspension with a dosage of 50 mg per mL. The medication contains diazoxide, USP, and the usual dose is not provided. The text also includes NDC codes and instructions for dispensing the medication, along with a warning not to exceed the recommended dose. The text is incomplete and difficult to read, so there may be additional information that is not available in this text.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
